Month: May 2021

NEW YORK, May 18, 2021 (GLOBE NEWSWIRE) — Lexington Realty Trust (“Lexington”) (NYSE:LXP), a real estate investment trust focused on single-tenant industrial real estate investments, today announced that Elizabeth Noe has been appointed to its Board of Trustees and the Audit Committee of the Board of Trustees, effective May 18, 2021. Ms. Noe recently retired from the global law firm Paul Hastings LLP, which she joined in 1995.  She served as a partner in the firm from February 2001 and as Chair of the Corporate Department from February 2010 until February 2020.  Ms. Noe is the Vice-chair and Chair-elect of the Board of Trustees of Agnes Scott College and has served as a Trustee of the College since July 2014.  T. Wilson Eglin, Chairman, Chief Executive Officer and President of Lexington Realty Trust, commented, “We are delighted...

GARDEN CITY, N.Y., May 18, 2021 (GLOBE NEWSWIRE) — Lifetime Brands, Inc. (NasdaqGS: LCUT), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, today posted an updated investor presentation to its website, to be used in investor meetings beginning this week. The presentation can be accessed at https://lifetimebrands.gcs-web.com/events-and-presentations. The presentation highlights the Company’s successful execution of its “Lifetime Brands 2.0” growth strategy, strong recent performance and increased long-term growth targets. Lifetime Brands has provided revised five-year financial objectives, including the following forward-looking non-GAAP financial measures:Financial Measure 5-Year ObjectiveAdjusted EBITDA $120 million, revised from $90+ millionAdjusted EBITDA...

EXTON, Pa., May 18, 2021 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera” or the “Company”) (Nasdaq: IDRA) today announced that it will not continue ILLUMINATE-301, the Company’s trial of tilsotolimod in combination with ipilimumab versus ipilimumab alone in patients with anti-PD-1 refractory advanced melanoma, to its overall survival (OS) primary endpoint. The Company reported in March 2021 that the trial did not meet its primary endpoint of objective response rate (ORR). Full results from the study will be presented in a future publication. “Since receiving the disappointing ORR results from ILLUMINATE-301, we have interrogated the full data set and consulted with our study Steering Committee, our partners at Bristol Myers Squibb (BMS), and other stakeholders regarding next steps for the trial. Our conclusion is that the...

MINNEAPOLIS, May 18, 2021 (GLOBE NEWSWIRE) — Jamf (NASDAQ: JAMF), the standard in Apple Enterprise Management, announced today that members of its management team will present at the following investor conferences:The Needham 16th Annual Technology & Media Virtual Conference on Thursday, May 20th at 11:45 AM Eastern Time; and The J.P. Morgan 49th Annual Global Technology, Media and Communications Virtual Conference on Monday, May 24th at 4:15 PM Eastern TimeWebcasts of these events will be available on the investor relations section of the Company’s website at https://ir.jamf.com/. About JamfJamf, the standard in Apple Enterprise Management, extends the legendary Apple experience people love to businesses, schools and government organizations through its software and the world’s largest online community of IT admins...

First Quarter EPS $0.12; Deleveraging Continues; Company Working Through Supply Chain Challenges WOONSOCKET, R.I., May 18, 2021 (GLOBE NEWSWIRE) — SUMR Brands (“SUMR Brands” or the “Company”) (NASDAQ: SUMR), a global leader in premium infant and juvenile products, today announced financial results for the fiscal first quarter ended April 3, 2021. Recent HighlightsNet sales were $36.2 million in the first quarter versus $40.3 million in the prior-year period, with the decline reflecting ongoing supply chain constraints and logistical issues, which have impeded product getting to market Aggregate SG&A declined to $9.4 million in the quarter compared to $11.6 million in last year’s comparable period (and $10.2 million in the fourth quarter of fiscal 2020), reflecting the shift in the Company’s distribution...

CALGARY, Alberta, May 18, 2021 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) has sold its gross overriding royalty (GORR) in the Marten Hills area of Alberta to Topaz Energy Corp. for gross cash proceeds of $102 million. The sale successfully closed today with a May 1, 2021 effective date. Cenovus will use the sale proceeds to reduce net debt, consistent with its commitment to use non-core asset sales to accelerate deleveraging to achieve the company’s interim net debt target of $10 billion. “This transaction demonstrates our ability to strategically identify opportunities in our portfolio to accelerate the deleveraging process,” said Alex Pourbaix, Cenovus President & Chief Executive Officer. “This is the first transaction of our broader initiative and we will continue to explore all options to create value...

DALLAS, May 18, 2021 (GLOBE NEWSWIRE) — A. H. Belo Corporation (NYSE: AHC) (the “Company”) today announced that its Board of Directors (the “Board”) has approved a reverse stock split of all of the issued and outstanding and treasury shares of common stock, par value $0.01 per share, of the Company, at a reverse stock split ratio of 1-for-4. The Company’s shareholders granted authority to the Board to effect the reverse stock split at the Company’s 2021 Annual Meeting of Shareholders held on May 13, 2021. The reverse stock split is expected to become effective at 12:01 a.m. Central Daylight Time on June 8, 2021 (the “Effective Time”). The Company’s Series A common stock will continue to trade on the New York Stock Exchange (“NYSE”) under the symbol “AHC” and is expected to begin trading on a post-split basis when the market opens...

MINNEAPOLIS, May 18, 2021 (GLOBE NEWSWIRE) — Sun Country Airlines Holdings, Inc. (“Sun Country Airlines”) (NASDAQ: SNCY) announced today that Dave Davis, President and Chief Financial Officer, will participate in the Ultra-Low-Cost-Carrier panel discussion at the Wolfe Research Transportation and Industrials Conference on Tuesday, May 25th at 10:20 AM EDT. A link to the live webcast of the panel discussion can be found on the investor relations section of Sun Country Airlines’ website at https://ir.suncountry.com/news-events/events-and-presentations. About Sun Country Airlines Sun Country Airlines is a new breed of hybrid low-cost air carrier that dynamically deploys shared resources across our synergistic scheduled service, charter and cargo businesses. Based in Minnesota, we focus on serving leisure and visiting friends and relatives...

ATLANTA, May 18, 2021 (GLOBE NEWSWIRE) — Mueller Water Products, Inc. (NYSE:MWA) (the “Company”) today priced an offering of $450,000,000 aggregate principal amount of 4.0% Senior Notes due 2029 (the “Notes”) at par.  The Notes are being offered in a private offering that is exempt from the registration requirements of the Securities Act of 1933 (the “Securities Act”). The Company intends to use the net proceeds from the offering, together with cash on hand, to redeem the Company’s existing senior notes due 2026. The Notes will be offered in the United States to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and outside the United States in accordance with Regulation S under the Securities Act.  The offer and sale of the Notes have not been registered under the Securities...

PRESS RELEASE Immunocore announces dosing of first patient with ImmTAV® bispecific molecule for chronic Hepatitis B IMC-I109V studied for the treatment of non-cirrhotic HBeAg-negative chronic hepatitis B (HBV) infection (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 18 May 2021) Immunocore Holdings Plc (Nasdaq: IMCR) (or the “Company”), a pioneering, clinical‐stage T cell receptor biotechnology company working to develop and commercialise a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease, today announces the dosing of the first patient in the first-in-human clinical trial of IMC-I109V, a new class of bispecific protein immunotherapy that is being developed for the treatment of patients with chronic hepatitis B (HBV) infection (CHB). Wholly owned...